OUR EXPERT NETWORK

• Decoding RNA's Circular Decisions: How HNRNPD Shapes circRNA Biogenesis And RNA Fate

  How do cells decide between circular and linear RNA? New insights into HNRNPD reveal mechanisms that could improve the design of future circRNA therapeutics.

• Beyond Gene Silencing: Harnessing Regulatory RNAs To Increase Gene Expression In Haploinsufficient Disease

  Can RNA therapeutics increase — not silence — gene expression? Regulatory RNA-targeting ASOs may redefine treatment for haploinsufficient diseases.

• Beyond The m⁷G Cap: How Non-Canonical RNA Capping Could Expand RNA Therapeutics

  Newly discovered non-canonical RNA caps are reshaping RNA biology and could inspire the next generation of more precise, programmable RNA therapeutics.

• Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches

  This article highlights government-funded resources available to de-risk nanomedicines, reviews principles of immunotoxicity testing, and discusses emerging methodologies.

• Bridging The Atlantic: A European Executive's Guide To Entering The U.S. RNA Market (Pt. 1)

  A practical roadmap for European biotech leaders navigating FDA expectations, market entry, and the strategic decisions that shape U.S. expansion.